Skip to Content

Tag: Inspire Medical

Also Noted

Inspire Medical sees significant growth in Q4 

January 10, 2023HME News Staff

MINNEAPOLIS – Inspire Medical, the maker of an FDA-approved neurostimulation device to treat obstructive sleep apnea, expects revenue of $137.5 million to $137.9 million for the fourth quarter of 2022, about a 76% increase year over year. It expects revenue for the full year to be $407.5 million to $407.9 million, about a 75% increase compared to 2021. “We are very pleased with our strong preliminary revenue performance in the fourth quarter primarily driven by higher utilization at existing...

CPAP Alternative, Inspire Medical, neurostimulation device, Obstructive Sleep Apnea

Read Full Articlered right arrow icon

Also Noted

Inspire Medical raises $37M for sleep apnea device

November 17, 2016HME News Staff

MAPLE GROVE, Minn. - Inspire Medical Systems has accumulated $37.5 million in venture funding as it prepares to increase sales of its pacemaker-sized, implantable device used to treat sleep apnea. New York-based investor Amazak Health led the round of funding, CEO Tim Herbert told the Minneapolis/St. Paul Business Journal. Previous investors, including OrbiMed Advisors and Medtronic, also participated in the round. The company received $12.5 million a few weeks ago and will get the rest next year....

Inspire Medical, Sleep Apnea

Read Full Articlered right arrow icon